News & Events

You are here

Australia and the Asia Pacific are fast becoming the destination of choice for the over US$140 billion international biotech industry ...

10/01/18

Australia and Asia Pacific offer international biotech industry a wealth of clinical trial and costs benefits

Australia and the Asia Pacific are fast becoming the destination of choice for the over US$140 billion international biotech industry ...

08/01/18

Novotech wins 2017 Asia Pacific Biotech CRO award

Leading Asia Pacific CRO Novotech has won Asia Pacific Biotech CRO Company of The Year award in Frost & Sullivan’s 2017 Best Practice Awards. 

“Over the past 20 years, Novotech has grown to become the leading contract research...

11/12/17

BioSpectrum Asia interviews Dr Yooni Kim on how she is growing the next generation of female biotech executives

As part of their 2017 Women In Biotech issue (pg29), BioSpectrum Asia interviewed Novotech Executive Director, Head of Asia Operations Dr Yooni Kim on how she is growing the next generation of female biotech executives. 

11/12/17

Novotech Update: Asia’s international clinical trial profile will continue to increase in 2018, says Novotech

Presenting at this year’s Outsourcing Clinical Trials East Asia 2017 in Seoul, Novotech CRO Chief Executive Officer Dr John Moller presented an overview on the opportunities and challenges of conducting multi regional clinical (MRCTs) trials in...

30/11/17

Novotech Update: Malaysian government invests in its early stage research industry and launches new Phase I clinical trial guidelines

Malaysia’s clinical trials industry body Clinical Research Malaysia (CRM) has launched the country’s first Phase I Clinical Trial Guidelines. The new guidelines present a standardised reference for First In Human (...

03/11/17

World Pharma Today: Increasing clinical trial competition within Asia to benefit sponsors says Novotech

In an article drafted for World Pharma Today, Novotech explains on how increasing clinical trial competition within Asia is of benefit to sponsors. 

...

03/11/17

World Pharma Today: Increasing clinical trial competition within Asia to benefit sponsors says Novotech

In an article drafted for World Pharma Today, Novotech explains on how increasing clinical trial competition within Asia is of benefit to sponsors. 

...

23/10/17

Novotech named a finalist in the 2017 Premier’s NSW Export Awards

Novotech has been named as a finalist in the Health and Biotechnology category of the upcoming 2017 Premier’s New South Wales Export Awards. 

“Novotech has had a terrific year of growth providing Australian clinical trial services to...

23/10/17

BioSpectrum Asia: Australia - A thriving lifescience hub with a global reach

In an interview with BioSpectrum Asia, Novotech CEO Dr John Moller provides his thoughts on the state of Australia's medical technologies, biotechnology and pharmaceutical (MTP) sector. ...

23/10/17

Novotech Update: China implements 5 key changes to accelerate clinical trial and drug approval timelines

With patients in China having to wait a minimum of six years to access medications already approved in Western markets, the combination of increasing disease burden and limited access to proven medication has resulted in growing pressure on the...

Pages